part_11_sigLeafLevel 2
Part 11 Subpart C - Electronic Signatures
Part 11 Subpart C of Title 21 CFR establishes the criteria for using electronic signatures in FDA-regulated activities. It defines requirements for signature authenticity, link to electronic
GET
/api/v1/systems/reg_fda_21cfr/nodes/part_11_sigCross-system equivalences0
No cross-system equivalences mapped for this node.